Clinical Trials
3 trialsNCT06605625 2025-10-28
VRiC
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT03061955 2024-10-04
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
Wake Forest University Health Sciences
Completed
NCT04355806 2020-04-21
Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors
Shanghai Pulmonary Hospital, Shanghai, China
Unknown